Page last updated: 2024-10-27

flurbiprofen and Lymphoma, Large B-Cell, Diffuse

flurbiprofen has been researched along with Lymphoma, Large B-Cell, Diffuse in 1 studies

Flurbiprofen: An anti-inflammatory analgesic and antipyretic of the phenylalkynoic acid series. It has been shown to reduce bone resorption in periodontal disease by inhibiting CARBONIC ANHYDRASE.
flurbiprofen : A monocarboxylic acid that is a 2-fluoro-[1,1'-biphenyl-4-yl] moiety linked to C-2 of propionic acid. A non-steroidal anti-inflammatory, analgesic and antipyretic, it is used as a pre-operative anti-miotic as well as orally for arthritis or dental pain.

Lymphoma, Large B-Cell, Diffuse: Malignant lymphoma composed of large B lymphoid cells whose nuclear size can exceed normal macrophage nuclei, or more than twice the size of a normal lymphocyte. The pattern is predominantly diffuse. Most of these lymphomas represent the malignant counterpart of B-lymphocytes at midstage in the process of differentiation.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lozanski, G1
Ballou, SP1
Kushner, I1

Other Studies

1 other study available for flurbiprofen and Lymphoma, Large B-Cell, Diffuse

ArticleYear
Effect of flurbiprofen on cytokine production by human monocytes and U-937 and THP-1 cell lines.
    The Journal of rheumatology, 1992, Volume: 19, Issue:6

    Topics: Cells, Cultured; Cytokines; Enzyme-Linked Immunosorbent Assay; Flurbiprofen; Humans; Interleukin-1;

1992